Your browser doesn't support javascript.
loading
Early, risk-adapted treatment with fludarabine in Binet stage A chronic lymphocytic leukemia patients: results of the CLL1 trial of the German CLL study group.
Hoechstetter, M A; Busch, R; Eichhorst, B; Bühler, A; Winkler, D; Eckart, M J; Vehling-Kaiser, U; Schimke, H; Jäger, U; Hurtz, H J; Hopfinger, G; Hartmann, F; Fuss, H; Abenhardt, W; Blau, I; Freier, W; Müller, L; Goebeler, M; Wendtner, C M; Bahlo, J; Fischer, K; Bentz, M; Emmerich, B; Döhner, H; Hallek, M; Stilgenbauer, S.
Afiliação
  • Hoechstetter MA; Department of Internal Medicine I, Klinikum Schwabing, Munich, Germany.
  • Busch R; Institute of Medical Statistics and Epidemiology, Technical University Munich, Munich, Germany.
  • Eichhorst B; Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany.
  • Bühler A; Department of Internal Medicine III, Ulm University, Ulm, Germany.
  • Winkler D; Department of Internal Medicine III, Ulm University, Ulm, Germany.
  • Eckart MJ; Internal Medicine, Hematology and Oncology Private Practice, Erlangen, Germany.
  • Vehling-Kaiser U; Oncological Private Practice, Landshut, Germany.
  • Schimke H; Internal Medicine, Hematology and Oncology Private Practice, Saarbrücken, Germany.
  • Jäger U; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Hurtz HJ; Internal Medicine, Hematology and Oncology Private Practice, Halle, Germany.
  • Hopfinger G; Department of Internal Medicine I, Division of Bone Marrow Transplantation, Medical University of Vienna, Vienna, Austria.
  • Hartmann F; Department of Hematology and Oncology, Klinikum Lippe-Lemgo, Lemgo, Germany.
  • Fuss H; Department of Hematology, Oncology and Palliative Medicine, Klinikum Bad Saarow, Bad Saarow, Germany.
  • Abenhardt W; Hematology and Oncology Private Practice, Munich, Germany.
  • Blau I; Hematology and Oncology Private Practice, Berlin, Germany.
  • Freier W; Hematology and Oncology Private Practice, Hildesheim, Germany.
  • Müller L; Hematology and Oncology Private Practice, Leer, Germany.
  • Goebeler M; Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.
  • Wendtner CM; Department of Internal Medicine I, Klinikum Schwabing, Munich, Germany.
  • Bahlo J; Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany.
  • Fischer K; Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany.
  • Bentz M; Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany.
  • Emmerich B; Department of Internal Medicine III, Klinikum Karlsruhe, Karlsruhe, Germany.
  • Döhner H; Interdisciplinary Oncology Center (IOZ) Private Practice, Munich, Germany.
  • Hallek M; Department of Internal Medicine III, Ulm University, Ulm, Germany.
  • Stilgenbauer S; Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany.
Leukemia ; 31(12): 2833-2837, 2017 12.
Article em En | MEDLINE | ID: mdl-28804126
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vidarabina / Leucemia Linfocítica Crônica de Células B / Antineoplásicos Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vidarabina / Leucemia Linfocítica Crônica de Células B / Antineoplásicos Idioma: En Ano de publicação: 2017 Tipo de documento: Article